News by subject: TRI

Abcentra LLC, a clinical-stage biopharmaceutical company specializing in coronary artery disease, presented the latest results from a Phase 2a pilot, placebo-controlled, randomized clinical trial of Orticumab, a new drug with...

Hinge Bio, Inc., a privately-held biotechnology company, today announced that Daniel Capon, Ph.D., Chief Scientific Officer, and Juha Punnonen, M.D., Ph.D., Chief Development Officer, are presenting data from the company's GEM-DIMER program targeting...

Medtronic plc , a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360tm, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment...

SeekIn Inc., a leader in blood-based cancer early detection and monitoring technology, today announced three additional validation studies that evaluate...

Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the...

-  ISB 2001 is a first-in-class T cell-engaging (TCE) trispecific antibody based on Ichnos' proprietary BEAT® platform that targets BCMA and CD38 on multiple myeloma (MM) cells. -  ISB 2001 exhibited superior cytotoxicity over teclistamab in bone...

Positive Phase 3 Study Results Included in Dr. Eric Donnenfeld's PresentationCo-Primary Symptom Endpoint of Pain Met Statistical Significance (P<0.025) and 7 of 11 Secondary Symptom Endpoints Met Statistical Significance (P<0.05), 12-Week...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the 2024 European Association of Urology congress (EAU) in Paris, France, highlighting the benefits of Blue Light...

Alkermes plc today announced the oral presentation of clinical data at the 2024 Congress of the Schizophrenia International Research Society (SIRS), which took place April 3-7, 2024 in Florence, Italy. Analyses were presented from a phase 3,...

Syndax Pharmaceuticals , a clinical stage biopharmaceutical company developing an innovative pipeline...

Johnson & Johnson announced today a new analysis of data from the PIONEER AF-PCI clinical trial demonstrating that...

HLS Therapeutics Inc. (HLS or the Company) , a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, today highlighted two data presentations at the 73rd Annual Scientific...

Servier strengthens its commitment to oncology through the launch of a trailblazing strategy, focused on honing its expertise in precision oncology to drive patient-centric impact Phase 1b data demonstrates safety profile and preliminary anti-tumor...

BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on the NurOwn® program tomorrow, April 9, at 8:00 AM Eastern...

Clover Biopharmaceuticals, Ltd.?(Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives...

Vivet Therapeutics ('Vivet'), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic disorders, today announces that it has dosed its first patient with its lead program VTX-801 in...

Boston Scientific Corporation has initiated the NAVIGATE-PF study of the FARAVIEWtm Software Module* when it is used to visualize and track the FARAWAVEtm Nav Pulsed Field Ablation (PFA) Catheter* for the treatment of patients with paroxysmal and...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced that it has submitted an Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) for a Phase III clinical trial...

Cynata Therapeutics Limited , a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce the completion of patient enrolment in its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU). CYP-006TK is...

Laekna (2105.HK) announced that the company has presented two internally-discovered preclinical candidates, in addition to a poster presentation on a clinical trial, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) in...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, age-related diseases, and chronic hepatitis B (CHB), announced today that it releases the latest results from three preclinical studies...

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCVs), today announced the publication of positive safety, immunogenicity, and...

?         Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction in acute pancreatitis events ? ?         Results demonstrate olezarsen may...

Medtronic plc , a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at...

V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal on statin therapy alone led to significant LDL-C reduction vs. clinician-determined usual care...

Results presented at ACC.24 showed that overall neutral results were due to directionally opposite effects in patients with reduced vs. preserved left ventricular ejection fraction   Heart failure patients with reduced ejection (HFrEF) had 45%...

Johnson & Johnson announced today that the U.S. Food...

Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world, announced that new data from its breakthrough product ASPYRE-Lung will be presented in three scientific...

Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) will be highlighted at the American Association for Cancer Research 2024 Annual Meeting in San Diego as scientists, clinicians and other health care...

Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and ThinkSono, a pioneering medical technology company specializing in ultrasound artificial intelligence (AI) guidance solutions, are introducing a new...

BETHESDA, Md., April 5, 2024 PRNewswire/ -- Precision Biologics, Inc. reports its lead monoclonal antibody, NEO-201, targets circulating human naïve regulatory T cells (Tregs) in both healthy donors and cancer patients. A poster presentation...

Bold Therapeutics, a clinical-stage biopharmaceutical company at the forefront of developing innovative metallotherapeutics, has announced that Dr. Do-Youn Oh's group at Seoul National University College of Medicine, Seoul, South Korea, will be...

SkylineDx is pleased to announce two forthcoming scientific publications at the European Association for Dermato-Oncology congress, April 4-6, 2024. These publications show Merlin test's (CP-GEP model) ability to identify early-stage cutaneous...

Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule inhibitors to target escape mutations in hematologic and solid malignancies, is pleased to announce the...

CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. This cutting-edge mobile solution is designed to revolutionize cardiac care...

Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced that it has been selected by Lindus Health, an "anti-CRO" running radically faster, more reliable clinical trials...

Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, will be presenting preclinical data on its next-generation anti-CD20 antibody, NAV-006, and ICAM-1 refractory antibody-drug...

WCG, the global leader in providing solutions that measurably improve the quality and efficiency of clinical research, today launched Total Feasibility, a new application on WCG's powerful ClinSpheretm technology platform that transforms the site...

IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming American Association for Cancer Research (AACR) Annual Meeting occurring in San Diego,...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to public health and escalating the burden on healthcare resources. Characterized by the accumulation of fat in the...

Esteemed Board-Certified Plastic Surgeon, Dr. Adam J. Rubinstein, has been honored with the 2024 Aesthetic and Anti-Aging Medicine World Congress (AMWC) Best Surgical Body Shaping Award for his exceptional work in total body and breast makeover...

In this free webinar, learn how to operationalize clinical research within new-to-research communities while ensuring patient engagement and education. Attendees will learn what challenges clinical trial participants face and how sites can address...

Microbion Corporation today announced that the company has published results from its topical pravibismane...

Rigel Pharmaceuticals, Inc. today announced a peer-reviewed publication in Leukemia & Lymphoma on data from an analysis...

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage biotechnology company advancing RNA immunotherapies to conquer cancer, announced...

The positive three-year follow-up results of the PHERGain clinical trial, sponsored by MEDSIR, demonstrating that one-third of patients with localized HER2-positive breast cancer can be cured without the need for chemotherapy, have been published in...

UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug...

ProfoundBio, a clinical-stage biotechnology company dedicated to developing novel antibody-drug conjugate (ADC) therapies for patients with cancer, today announced its participation at the upcoming American Association for Cancer Research (AACR)...

myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living...